The US Preventive Services Task Force recently issued a draft recommendation to lower the starting age of colorectal cancer screening (CRC) from 50 to 45. We examine both the potential benefits and harms of expanding screening to a younger age group.
More
Telemedicine visits for urinary tract infections (UTIs) were associated with more appropriate antibiotic prescribing and decreased use of diagnostic and follow-up resources than virtual visits, according to the results of a primary care network study published yesterday in Infection Control and Hospital Epidemiology.
More
Screenings save lives, but can do serious harm too
More
“Our main goal was to change the framing of the conversation from the important but relatively narrow focus on specific outcomes [in other rankings] to also look more broadly at a range of other things,” Dr. Vikas Saini said. “There are number of other factors that can be measured and that should matter.”
More
This Teachable Moment advocates for considering a patient’s implantable cardioverter defibrillator in discussions regarding a do-not-resuscitate order.
More
As countries around the world seek to safely reopen businesses, schools, and other facets of society, mask use in the community to prevent the spread of SARS-CoV-2, in conjunction with other low-cost, low-tech, commonsense public health practices, is and will remain critical.
More
False negatives are not the only troublesome outcome of a faulty coronavirus test.
More
Women held in a South Georgia immigration detention center were referred to a gynecologist for problems unrelated to their reproductive health and were pressured to undergo unnecessary surgeries, according to a group of medical experts reviewing their complaints.
More
The future of Covid-19 treatment is cloudier after the FDA approved Gilead Sciences Inc.'s remdesivir, the first virus treatment to get full authorization in the U.S.
More
The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease.
More
Communities of color are suffering disproportionately from coronavirus. The social determinants of health that lead to higher concentrations of hypertension and diabetes can be mitigated by investment in primary care.
More
A randomized, controlled clinical trial involving high-risk healthcare workers found that pre-exposure prophylaxis with hydroxychloroquine once or twice weekly did not significantly reduce COVID-19 compared with placebo, researchers reported late last week in Clinical Infectious Diseases.
More
The antiviral drug remdesivir had no substantial impact on the survival of COVID-19 patients or the length of their hospital stays, according to a World Health Organization (WHO) clinical trial.
More
This Viewpoint proposes that sensible medicine for COVID-19 may better serve patients than unreasoned treatment using unproven interventions in the moment.
More
A grim reality is setting in across the U.S. hospital sector: a surge in coronavirus infections is encroaching while most facilities are still recovering from the onset of the pandemic.
More
Javaid Perwaiz, a former OB/GYN, faces trial this week in Norfolk, Va. He is charged with health-care fraud.
More
Rural hospitals are struggling in the pandemic. But will a new payment model help or hurt?
More
In a keynote address for the US Deprescribing Research Network Conference, Dr. Cara Tannenbaum urged participants to reimagine the future of deprescribing research.
More
Did Trump receive the "best care possible"? Or was he overtreated?
More
A study late last week found that convalescent plasma (CP) treatment did not significantly reduce mortality, but improved hospital discharge rates for patients 65 and older.
More